Vaccines
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates
| 3 min read
WIRB-Copernicus IRB will give priority to the institutional review board (IRB) review of potentially life-saving COVID-19 vaccines and medications and waive their initial protocol review fees
| 1 min read
Researchers' work is providing crucial leads for guiding experimental efforts toward the vaccine development against the novel pneumonia (COVID-19) caused by the virus
| 2 min read
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development
| 2 min read
Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin
| 2 min read
The researchers making this claim are even more optimistic about North America, stating that the disease could be almost completely eliminated by 2040
| 2 min read
A newly discovered mechanism allows the immune system to detect and respond to HIV
| 5+ min read
The first strain of influenza virus we encounter during childhood sets the course of how our immune system responds to exposures later in life
| 5 min read
Study is the first to experimentally determine which byproducts from the mutation of tumors have the ability to provoke the immune system into recognizing and killing cancer cells in multiple myeloma patients
| 2 min read
Discovery promises to aid production of protein-based drugs, vaccines, other biomaterials
| 3 min read
